Fingertip blood testing proves viable for cannabis detection

Researchers developed a breakthrough method for detecting THC and its metabolite THC-COOH in tiny blood samples collected from fingertips using dried capillary blood spots (DBS). This innovative approach achieved extraction efficiencies greater than 80% for both compounds—a significant improvement over previous methods that struggled with cannabinoid detection. The new technique uses a two-step extraction process involving dimethyl sulfoxide followed by methanol, making it practical for minimal-invasive testing.

The study compared 159 blood samples from recreational cannabis users, measuring cannabinoid levels in both capillary (fingertip) and traditional venous (arm) blood. The results showed that THC-COOH levels matched closely between the two collection methods (median ratio of 1.09), making fingertip testing reliable for detecting cannabis metabolites. However, THC itself showed more variability between capillary and venous blood, with capillary samples containing roughly twice as much THC on average—an important distinction for accurate cannabis testing.

This advancement has significant implications for cannabis research and testing programs. The ability to collect blood via fingertip rather than venous draws makes large-scale studies more feasible and less invasive for participants. The strong correlation between THC-COOH measurements in capillary and venous samples suggests this method could be valuable for cannabis-use monitoring, workplace testing, and clinical research, while the THC variability highlights the need for careful interpretation when measuring active cannabinoid levels in capillary samples.